Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Walters

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|December 13, 2021
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell DiseaseJulie Kanter, Mark C Walters, Lakshmanan Krishnamurti, et al.
Blood Advances|September 1, 2019
Related and unrelated donor transplantation for β-thalassemia major: results of an international surveyChunfu Li, Vikram Mathews, Soyoung Kim, et al.
The Lancet. Haematology|September 10, 2019
Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort studyMary Eapen, Ruta Brazauskas, Mark C Walters, et al.
Lancet (London, England)|November 11, 2024
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trialJanet L Kwiatkowski, Mark C Walters, Suradej Hongeng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 2018
Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH TrialShalini Shenoy, Mark C Walters, Alex Ngwube, et al.
Transplantation and Cellular Therapy|March 29, 2026
Gene therapy for sickle cell disease: Practice recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene TherapyAkshay Sharma, Adetola Kassim, Alexis Thompson, et al.
The New England Journal of Medicine|June 11, 2026
Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell DiseaseHaydar Frangoul, Josu de la Fuente, Yogi Chopra, et al.
Iscience|May 31, 2022
High-level correction of the sickle mutation is amplified <i>in vivo</i> during erythroid differentiationWendy Magis, Mark A DeWitt, Stacia K Wyman, et al.
American Journal of Hematology|January 15, 2019
Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot studyLakshmanan Krishnamurti, Donna S Neuberg, Keith M Sullivan, et al.
Bone Marrow Transplantation|May 7, 2021
Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantationDeborah Friedman, Allen J Dozor, Jordan Milner, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|December 13, 2021
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell DiseaseJulie Kanter, Mark C Walters, Lakshmanan Krishnamurti, et al.
Blood Advances|September 1, 2019
Related and unrelated donor transplantation for β-thalassemia major: results of an international surveyChunfu Li, Vikram Mathews, Soyoung Kim, et al.
The Lancet. Haematology|September 10, 2019
Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort studyMary Eapen, Ruta Brazauskas, Mark C Walters, et al.
Lancet (London, England)|November 11, 2024
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trialJanet L Kwiatkowski, Mark C Walters, Suradej Hongeng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 2018
Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH TrialShalini Shenoy, Mark C Walters, Alex Ngwube, et al.
Transplantation and Cellular Therapy|March 29, 2026
Gene therapy for sickle cell disease: Practice recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene TherapyAkshay Sharma, Adetola Kassim, Alexis Thompson, et al.
The New England Journal of Medicine|June 11, 2026
Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell DiseaseHaydar Frangoul, Josu de la Fuente, Yogi Chopra, et al.
Iscience|May 31, 2022
High-level correction of the sickle mutation is amplified <i>in vivo</i> during erythroid differentiationWendy Magis, Mark A DeWitt, Stacia K Wyman, et al.
American Journal of Hematology|January 15, 2019
Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot studyLakshmanan Krishnamurti, Donna S Neuberg, Keith M Sullivan, et al.
Bone Marrow Transplantation|May 7, 2021
Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantationDeborah Friedman, Allen J Dozor, Jordan Milner, et al.
Pageof 9